Max Taquet
MSc BM BCh MRCPsych PhD
Associate Professor
- Specialty Registrar in Psychiatry, Oxford Health NHS Foundation Trust
- Tutor for graduates (evidence-based medicine), Magdalen College
I am an Associate Professor with backgrounds in both clinical psychiatry and engineering. Prior to studying medicine at the University of Oxford, I was a research fellow in engineering at Harvard Medical School and the Boston Children's Hospital.
My research seeks to use big data (including electronic health records, brain imaging, and mobile phone data) to help characterise and treat psychiatric disorders. By interrogating large multimodal datasets, I aim to gain insight into the complexity of mental illness, including its granular dynamics at the symptom level, its transdiagnostic nature, and its link with 'physical' illnesses (and COVID-19 in particular); and to translate this insight into treatment targets.
Key publications
The recombinant shingles vaccine is associated with lower risk of dementia.
Journal article
Taquet M. et al, (2024), Nat Med, 30, 2777 - 2781
12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study.
Journal article
De Giorgi R. et al, (2024), EClinicalMedicine, 74
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.
Journal article
Taquet M. et al, (2023), Nat Med, 29, 2498 - 2508
Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Journal article
Taquet M. et al, (2022), Lancet Psychiatry, 9, 815 - 827
Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
Journal article
Taquet M. et al, (2021), PLoS Med, 18
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.
Journal article
Taquet M. et al, (2021), Lancet Psychiatry, 8, 416 - 427
Recent publications
ntipsychotic Potential of Low-Dose Methotrexate: A Retrospective Cohort Study Based on Electronic Health Records
Preprint
Corsi-Zuelli F. et al, (2026)
ssociations between herpes zoster vaccination and herpes zoster with dementia risk in APOE‐e4 carriers and non‐carriers
Journal article
Davitte J. et al, (2025), Alzheimer's & dementia : the journal of the Alzheimer's Association, 21
Treatments for Depression and the Risk of Dementia: A 23‐Year Cohort Study Using Akrivia Health Secondary Mental Healthcare Data
Journal article
Kontari P. et al, (2025), Alzheimer's & dementia : the journal of the Alzheimer's Association, 21
Decoding Treatment Choice: Genetic and Phenotypic Analyses of Long-term Antidepressant Acceptability
Preprint
Walker A. et al, (2025)
Glucagon-like peptide-1 receptor agonists for major neurocognitive disorders.
Journal article
De Giorgi R. et al, (2025), J Neurol Neurosurg Psychiatry, 96, 870 - 883
